Skip to content

希邦医疗

US · SIBN #3357 按市值排名 上市于 2018
19.68 -0.23 -1.16%
实时 - 追踪5344个代码 - 心跳于135秒前 · 2026-10-16 20:02

✦ 量化股权信号 计算方式说明

减持
  • 最近一期（2026/Q3）披露持股的机构数量减少了3家。
  • 机构持股总比例下降了4.3个百分点。

机构持股

机构持股比例
109.48% -4.35pp
机构数量
215 -3
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund90.82%
Hedge Fund15.64%
Individual/Insider3.31%
Public Company1.66%
Private Company0.76%
Insurance Company0.25%
Government Pension Fund0.21%
Family Office/Trust0.14%

主要股东 截至 2026-06-30

First Light Asset Management, LLC 18.14% · 8.13M 股
BlackRock 8.20% · 3.68M 股
Cadian Capital Management, LP 7.47% · 3.35M 股
American Century Investment Management 5.60% · 2.51M 股
Vanguard Capital Management, LLC 4.75% · 2.13M 股
Brown Advisory Incorporated 4.63% · 2.08M 股
Granahan Investment Management, LLC 4.31% · 1.93M 股
Impax Asset Management Group Plc 3.18% · 1.43M 股
Gilder Gagnon Howe & Co. LLC 2.80% · 1.25M 股
Paradigm Capital Management, Inc. 2.75% · 1.23M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 13次买入 · 37次卖出

姓名职务持股比例
Laura Francis Chief Executive Officer 0.96%
Gregory Hinckley Independent Director 0.38%
Anthony Recupero President of Commercial Operations 0.36%
Michael Pisetsky Chief Business & Legal Affairs Officer 0.32%
John Freund Independent Director 0.30%
Jeffrey Dunn Executive Chairperson 0.19%
Timothy Davis Lead Independent Director 0.15%
Anshul Maheshwari Chief Financial Officer 0.12%
Jeryl Hilleman Independent Director 0.07%
Mika Nishimura Independent Director 0.07%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-10-04 Anshul Maheshwari Chief Financial Officer Intent to Sell (Form 144) -1,731 $18.08
2026-09-30 Jeffrey Dunn Executive Chairperson Derivative Exercise and Sale -20,000 $4.68–18.47
2026-08-31 Jeffrey Dunn Executive Chairperson Derivative Exercise and Sale -20,000 $4.68–18.91
2026-08-23 Laura Francis Chief Executive Officer Automatic Disposition -25,972 $20.12
2026-08-23 Anshul Maheshwari Chief Financial Officer Automatic Disposition -11,636 $20.11
2026-08-20 Laura Francis Chief Executive Officer Automatic Disposition -55,807 $19.46–20.02
2026-08-20 Anshul Maheshwari Chief Financial Officer Automatic Disposition -16,975 $19.55–20.02
2026-08-20 Anshul Maheshwari Chief Financial Officer Intent to Sell (Form 144) -11,228 $19.48
2026-08-18 Anshul Maheshwari Chief Financial Officer Intent to Sell (Form 144) -5,747 $19.14
2026-08-16 Laura Francis Chief Executive Officer Open Market Disposition -14,956 $18.63–18.68
2026-08-16 Anshul Maheshwari Chief Financial Officer Open Market Disposition -4,665 $18.62–18.68
2026-08-16 Michael Pisetsky Chief Business & Legal Affairs Officer Open Market Disposition -3,725 $18.62–18.65
2026-08-02 Jeffrey Dunn Executive Chairperson Derivative Exercise and Sale -20,000 $4.68–18.46
2026-07-01 Anshul Maheshwari Chief Financial Officer Open Market Disposition -3,317 $16.73–16.80
2026-07-01 Michael Pisetsky Chief Business & Legal Affairs Officer Open Market Disposition -3,134 $16.70–16.86
2026-06-04 Jeffrey Dunn Executive Chairperson Open Market Disposition -3,575 $15.25
2026-06-03 Timothy Davis Lead Independent Director Other Acquisition +10,957 --
2026-06-03 Jeryl Hilleman Independent Director Other Acquisition +10,957 --
2026-06-03 John Freund Independent Director Other Acquisition +10,957 --
2026-06-03 Jeffrey Dunn Executive Chairperson Other Acquisition +10,957 --

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 20:02:21 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

希邦医疗 讨论区 0 条评论

发表评论